Christopher John Kenney
Chief Medical Officer · Xenon Pharmaceuticals Inc.
- 2026
- Sep 1, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher John Kenney files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ian Mortimer - $21.42M in XENE purchases and sales in the last 12 months
- Steven Gannon - $641K in XENE purchases and sales in the last 12 months
- Thomas Patrick Kelly - $560K in XENE purchases and sales in the last 12 months
- Andrea Difabio - $231K in XENE purchases and sales in the last 12 months
- Gary Patou - $70K in XENE purchases and sales in the last 12 months
- Gillian Cannon - $63K in XENE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher John Kenney?
Christopher John Kenney is a corporate insider, tracked as Chief Medical Officer of Xenon Pharmaceuticals Inc. (XENE). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Christopher John Kenney submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Christopher John Kenney been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($670K) across all tracked filings.
